Hope into Reality

It is only through research that we can build a future in which no family will have to fear losing a loved one to prostate cancer.

But we’re not just here to add years to life; we’re also about adding life to years. Prostate cancer and the way it is currently treated brings physical and mental side effects, cuts too many lives short, and steals away the time that families should be able to spend together and enjoy. Our vision is a world where people are free from the impact of prostate cancer.

Our mission is that together, we will develop and deliver breakthrough medicines and treatments. We only fund research, and we prioritise maintaining a deep understanding of the needs and perspectives of patients and their families and involve them directly in our decision-making to guarantee that everything we do is relevant to the people it matters to – families affected by prostate cancer.

Our world-class scientists are dedicated to creating brand new prostate cancer treatments with the potential to reduce the side effects, dramatically cut the cost of treatment and ultimately to change the outcome. If we act now to support the science which can turn hope into reality, the next generation of men won’t have to fear a prostate cancer diagnosis.

Our History

A tightly focused research charity, the PCRC was founded in 1988 by Professor John Masters, a scientist who was passionate about finding new treatments for prostate cancer, and painfully aware of the lack of funding into advanced prostate cancer. He saw a growing need for new treatments as the population of the UK was ageing and more and more men received a diagnosis of advanced prostate cancer.

Every year more men are dying of prostate cancer. Men need new and more effective therapy. Please help our world class scientists improve survival for the next generation of men with life-threatening prostate cancer. It is only through research that we can make progress.

Professor John Masters PCRC Founder

How We Work

Our Research Strategy is based on the core values of: funding innovative and ambitious research; collaboration; promoting the careers of young scientists; and funding research into accessible treatments which will reduce the costs and burden on the NHS.

When selecting projects to fund, we use the expertise of our internal research team and our Scientific Advisory Committee to ensure a project is scientifically world-class. We use our Patient Voice Groups to ensure a project is relevant to people with prostate cancer. We encourage and support innovation with the understanding that the more innovative something is, the more risk comes with it.

Once we make an award to a scientist, the relationship doesn’t stop. We monitor and evaluate that project’s performance the whole way. We help our researchers maximise their impact by connecting them with patients, so that they gain a deeper understanding of patient challenges. We help our scientists build new collaborations and partnerships with other scientists and industry, so they can share ideas, resources, and expertise.

By working in this way, we have the best chance of saving and improving lives.

Our Current Research

At Prostate Cancer Research, we have a diverse portfolio of projects at some of the UK’s leading institutions in prostate cancer, ranging from early-stage biological insights to drug development. Our academic research is focused on two core themes: (1) improving the classifications of advanced prostate cancer and our ability to predict which treatments will work best for individual patients based on their particular prostate cancer subtype; and (2) discovering new treatments for advanced prostate cancer by investigating how to contain cancerous cells within the prostate and prevent it from becoming advanced, and finding therapies for when the disease has become advanced.

The 2019 PCRC Impact Report was produced to communicate our impact and look for ways to improve. Assessing our past achievements and present methods helps us to be even more effective in the future.

Press enter or esc to cancel